Clinical Trial Update: Neuroinflammation in COVID-19 and Depression

View source ↗

Summary

A clinical trial investigating neuroinflammation in patients with COVID-19 and major depressive disorder has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Major Depressive Disorder

Snippet

Sponsor: Centre for Addiction and Mental Health | Conditions: Major Depressive Episode, Covid19 | Status: COMPLETED